価格表

在庫・価格 : 2024年05月07日 00時46分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
DNA Modification Kit, One-Step, Methylamp (40 samples)
データシート
P-1010-1 EPGエピジェンテックグループ
Epigentek Group Inc.
1 kit ¥34,000
(未発注)
追加

在庫・価格 : 2024年05月07日 00時46分 現在

DNA Modification Kit, One-Step, Methylamp (40 samples)

  • 商品コード:P-1010-1
  • メーカー:EPG
  • 包装:1kit
  • 価格: ¥34,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Collerton J et al. Acquisition of aberrant DNA methylation is associated with frailty in the very old: findings from the Newcastle 85+ Study. Biogerontology 2014 Aug;15(4):317-28
Collerton J et al
2014/01/01
PubMed
2 Treilleux I et al. The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase. Histopathology 2007 Jul;51(1):63-9
Treilleux I et al
2007/01/01
PubMed
3 Otsubo T et al. SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br. J. Cancer 2008 Feb;98(4):824-31
Otsubo T et al
2008/01/01
PubMed
4 Cheetham S et al. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2"deoxycytidine to increase SPARC expression and improve therapy response. Br. J. Cancer 2008 Jun;98(11):1810-9
Cheetham S et al
2008/01/01
PubMed
5 Novara F et al. Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood. Hum. Genet. 2009 Oct;126(4):511-20
Novara F et al
2009/01/01
PubMed
6 Cheng ZD et al. Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods. Chin J Cancer 2010 Feb;29(2):163-6
Cheng ZD et al
2010/01/01
PubMed
7 Pang JC et al. KIAA0495/PDAM is frequently downregulated in oligodendroglial tumors and its knockdown by siRNA induces cisplatin resistance in glioma cells. Brain Pathol. 2010 Nov;20(6):1021-32
Pang JC et al
2010/01/01
PubMed
8 Ferguson S et al. The dual role of HLXB9 in leukemia. Pediatr Blood Cancer 2011 Mar;56(3):349-52
Ferguson S et al
2011/01/01
PubMed
9 Thathia SH et al. Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity. Haematologica 2012 Mar;97(3):371-8
Thathia SH et al
2012/01/01
PubMed
10 Calabuig-Fari単as S et al. Characterization of a new human cell line (CH-3573) derived from a grade II chondrosarcoma with matrix production. Pathol. Oncol. Res. 2012 Oct;18(4):793-802
Calabuig-Fari単as S et al
2012/01/01
PubMed
11 Yuasa Y et al. Insulin-like growth factor 2 hypomethylation of blood leukocyte DNA is associated with gastric cancer risk. Int. J. Cancer 2012 Dec;131(11):2596-603
Yuasa Y et al
2012/01/01
PubMed
12 Gallardo A et al. Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. Br. J. Cancer 2012 Apr;106(8):1367-73
Gallardo A et al
2012/01/01
PubMed
13 Li KK et al. MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3). Brain Pathol. 2013 Jul;23(4):413-25
Li KK et al
2013/01/01
PubMed
14 Wang CX et al. Aberrant DNA methylation and epigenetic inactivation of hMSH2 decrease overall survival of acute lymphoblastic leukemia patients via modulating cell cycle and apoptosis. Asian Pac. J. Cancer Prev. 2014;15(1):355-62
Wang CX et al
2014/01/01
PubMed
15 Gautrey HE et al. DNA methylation abnormalities at gene promoters are extensive and variable in the elderly and phenocopy cancer cells. FASEB J. 2014 Jul;28(7):3261-72
Gautrey HE et al
2014/01/01
PubMed
16 Tang W et al. RhoBTB2 gene in breast cancer is silenced by promoter methylation. Int. J. Mol. Med. 2014 Mar;33(3):722-8
Tang W et al
2014/01/01
PubMed
17 Wu X et al. Epigenetic signature of chronic cerebral hypoperfusion and beneficial effects of S-adenosylmethionine in rats. Mol. Neurobiol. 2014 Dec;50(3):839-51
Wu X et al
2014/01/01
PubMed
18 van Otterdijk SD et al. Aberrations in DNA methylation are detectable during remission of acute lymphoblastic leukemia and predict patient outcome. Epigenomics 2015;7(1):35-45
van Otterdijk SD et al
2015/01/01
PubMed
19 Gabriel AS et al. Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia. Epigenetics 2015;10(8):717-26
Gabriel AS et al
2015/01/01
PubMed
20 Gao XZ et al. Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2"-deoxycytosine with potential therapeutic significance in Burkitt"s lymphoma. Mol Med Rep 2016 Feb;13(2):1269-74
Gao XZ et al
2016/01/01
PubMed
21 Ntranos A et al. Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis. Brain 2019 Mar;142(3):647-661
Ntranos A et al
2019/01/01
PubMed
22 Van Haute L et al. NSUN2 introduces 5-methylcytosines in mammalian mitochondrial tRNAs. Nucleic Acids Res 2019 09;47(16):8720-8733
Van Haute L et al
2019/01/01
PubMed
23 Liang X et al. The DNMT1/miR-34a Axis Is Involved in the Stemness of Human Osteosarcoma Cells and Derived Stem-Like Cells. Stem Cells Int 2019;2019:7028901
Liang X et al
2019/01/01
PubMed
24 Cao X et al. The DNMT1/miR-34a/FOXM1 Axis Contributes to Stemness of Liver Cancer Cells. J Oncol 2020;2020:8978930
Cao X et al
2020/01/01
PubMed
  • No.: 1
  • 文献情報:
    Collerton J et al. Acquisition of aberrant DNA methylation is associated with frailty in the very old: findings from the Newcastle 85+ Study. Biogerontology 2014 Aug;15(4):317-28
    Collerton J et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Treilleux I et al. The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase. Histopathology 2007 Jul;51(1):63-9
    Treilleux I et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Otsubo T et al. SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br. J. Cancer 2008 Feb;98(4):824-31
    Otsubo T et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Cheetham S et al. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2"deoxycytidine to increase SPARC expression and improve therapy response. Br. J. Cancer 2008 Jun;98(11):1810-9
    Cheetham S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Novara F et al. Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood. Hum. Genet. 2009 Oct;126(4):511-20
    Novara F et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Cheng ZD et al. Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods. Chin J Cancer 2010 Feb;29(2):163-6
    Cheng ZD et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Pang JC et al. KIAA0495/PDAM is frequently downregulated in oligodendroglial tumors and its knockdown by siRNA induces cisplatin resistance in glioma cells. Brain Pathol. 2010 Nov;20(6):1021-32
    Pang JC et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Ferguson S et al. The dual role of HLXB9 in leukemia. Pediatr Blood Cancer 2011 Mar;56(3):349-52
    Ferguson S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Thathia SH et al. Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity. Haematologica 2012 Mar;97(3):371-8
    Thathia SH et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Calabuig-Fari単as S et al. Characterization of a new human cell line (CH-3573) derived from a grade II chondrosarcoma with matrix production. Pathol. Oncol. Res. 2012 Oct;18(4):793-802
    Calabuig-Fari単as S et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Yuasa Y et al. Insulin-like growth factor 2 hypomethylation of blood leukocyte DNA is associated with gastric cancer risk. Int. J. Cancer 2012 Dec;131(11):2596-603
    Yuasa Y et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Gallardo A et al. Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. Br. J. Cancer 2012 Apr;106(8):1367-73
    Gallardo A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Li KK et al. MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3). Brain Pathol. 2013 Jul;23(4):413-25
    Li KK et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Wang CX et al. Aberrant DNA methylation and epigenetic inactivation of hMSH2 decrease overall survival of acute lymphoblastic leukemia patients via modulating cell cycle and apoptosis. Asian Pac. J. Cancer Prev. 2014;15(1):355-62
    Wang CX et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Gautrey HE et al. DNA methylation abnormalities at gene promoters are extensive and variable in the elderly and phenocopy cancer cells. FASEB J. 2014 Jul;28(7):3261-72
    Gautrey HE et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Tang W et al. RhoBTB2 gene in breast cancer is silenced by promoter methylation. Int. J. Mol. Med. 2014 Mar;33(3):722-8
    Tang W et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Wu X et al. Epigenetic signature of chronic cerebral hypoperfusion and beneficial effects of S-adenosylmethionine in rats. Mol. Neurobiol. 2014 Dec;50(3):839-51
    Wu X et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    van Otterdijk SD et al. Aberrations in DNA methylation are detectable during remission of acute lymphoblastic leukemia and predict patient outcome. Epigenomics 2015;7(1):35-45
    van Otterdijk SD et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Gabriel AS et al. Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia. Epigenetics 2015;10(8):717-26
    Gabriel AS et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Gao XZ et al. Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2"-deoxycytosine with potential therapeutic significance in Burkitt"s lymphoma. Mol Med Rep 2016 Feb;13(2):1269-74
    Gao XZ et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Ntranos A et al. Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis. Brain 2019 Mar;142(3):647-661
    Ntranos A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Van Haute L et al. NSUN2 introduces 5-methylcytosines in mammalian mitochondrial tRNAs. Nucleic Acids Res 2019 09;47(16):8720-8733
    Van Haute L et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Liang X et al. The DNMT1/miR-34a Axis Is Involved in the Stemness of Human Osteosarcoma Cells and Derived Stem-Like Cells. Stem Cells Int 2019;2019:7028901
    Liang X et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Cao X et al. The DNMT1/miR-34a/FOXM1 Axis Contributes to Stemness of Liver Cancer Cells. J Oncol 2020;2020:8978930
    Cao X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed